Patents by Inventor Hans Pannekoek

Hans Pannekoek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Factor VIII polypeptide having factor VIII:C activity
    Patent number: 8546332
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: October 1, 2013
    Assignee: Stichting Sanquin Bloedvoorziening
    Inventors: Petrus Johannes Lenting, Jan Aart Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek, Hans-Peter Schwarz, Friedrich Scheiflinger
  • FACTOR VIII POLYPEPTIDE HAVING FACTOR VIII:C ACTIVITY
    Publication number: 20110118188
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Application
    Filed: February 19, 2009
    Publication date: May 19, 2011
    Applicant: STICHTING SANQUIN BLOEDVOORZIENING
    Inventors: PETRUS JOHANNES LENTING, JAN AART VAN MOURIK, KOENRAAD MERTENS, HANS PANNEKOEK, PETER TURECEK, HANS-PETER SCHWARZ, FRIEDRICH SCHEIFLINGER
  • Factor VIII polypeptide having factor VIII:C activity
    Patent number: 7544660
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: June 9, 2009
    Assignee: Stichting Sanquin Bloedvoorziening
    Inventors: Petrus Johannes Lenting, Jan Aart Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek, Hans-Peter Schwarz, Friedrich Scheiflinger
  • Nuclear Receptors Agonists for Treatment of Atherosclerosis and/or Related Cardiovascular Disease
    Publication number: 20090035345
    Abstract: The invention relates to the use of an agonist of one or more of the nuclear receptors TR3, MINOR and NOT for the preparation of a medicament for the treatment of cardiovascular disease, in particular in-stent restenosis and/or vein-graft disease. The invention further relates to medical devices, such as stents and cuffs, that are coated with the agonist, or in which the agonist is incorporated and which are for use in the treatment of in-stent restenosis or vein-graft disease.
    Type: Application
    Filed: June 15, 2006
    Publication date: February 5, 2009
    Applicant: ACADEMISCH MEDISCH CENTRUM, BUREAU
    Inventors: Caroline Jacoba Maria De Vries, Hans Pannekoek, Vivian De Waard, Elisabeth Karin Arkenbout
  • Factor VIII polypeptide having factor VIII:C activity
    Publication number: 20060160994
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Application
    Filed: November 12, 2004
    Publication date: July 20, 2006
    Applicant: Baxter Aktiengesellschaft
    Inventors: Petrus Lenting, Jan Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek, Hans-Peter Schwarz, Friedrich Scheiflinger
  • Factor VII polypeptide having factor VII:C activity
    Patent number: 6919311
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Grant
    Filed: May 10, 2001
    Date of Patent: July 19, 2005
    Assignee: Stichting Sanquin Bloedvoorziening
    Inventors: Petrus Johannes Lenting, Jan Aart Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek, Hans-Peter Schwarz, Friedrich Scheiflinger
  • FACTOR VIII POLYPEPTIDE HAVING FACTOR VIII:C ACTIVITY
    Publication number: 20050074836
    Abstract: Factor VIII polypeptides having FVIII:C activity that contain modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII, characterized by the binding affinity to low density lipoprotein receptor protein, and methods for producing the same.
    Type: Application
    Filed: May 10, 2001
    Publication date: April 7, 2005
    Inventors: Petrus Lenting, Jan Van Mourik, Koenraad Mertens, Hans Pannekoek, Peter Turecek, Hans-Peter Schwarz, Friedrich Scheiflinger
  • Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
    Patent number: 6346513
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Factor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: February 12, 2002
    Assignee: Baxter Trading GmbH
    Inventors: Albert Johannes Joseph Van Ooyen, Hans Pannekoek, Martinus Philippus Verbeet, Robert Willem Van Leen
  • Proteins with Factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
    Patent number: 6316226
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Pactor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: April 3, 1995
    Date of Patent: November 13, 2001
    Assignee: Baxter Trading GmbH
    Inventors: Albert Johannes Joseph Van Ooyen, Hans Pannekoek, Martinus Philippus Verbeet, Robert Willem Van Leen
  • Proteins with factor VIII activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
    Patent number: 5171844
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Factor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: December 15, 1992
    Assignee: Gist-Brocades N.W.
    Inventors: Albert J. J. van Ooyen, Hans Pannekoek, Martinus P. Verbeet, Robert W. van Leen